RICE group 🧠🧬🔬

The last remaining work of my PhD got published today 🥳 In this communication, we highlight the possible effects of long term sample storage on blood DNA methylation patterns. 🧬👩🏻‍🔬 @VanmierloTim @rice_science mdpi.com/1422-0067/25/6…

Let this be an encouragement to fellow scientists struggling with obtaining the oh so desired significant and positive data. Data from any experiment deserves to be shared with the field 📚 ☀

New paper alert 🚨🚨 Check out our most recently published paper, by Lieve van Veggel, about the ongoing search for an EAAT activator. @VanmierloTim @BIOMED_UHasselt @MaastrichtU @UniLeidenNews pubs.acs.org/doi/10.1021/ac…

Happy International Day of Women and Girls in Science! February 11!🔬🧪🧫 #WomenInScience #WomenAndGirlsInScience #WomenInScienceDay #microscopy

Excited to present my poster today at the Glia conference in Berlin about our latest publication on DNA methylation and myelination in Multiple sclerosis. 🧠🧬 #glia2023 #myelin @VanmierloTim @rice_science

📣 JOB ALERT 📣 I'm looking for an enthusiastic PhD student who is passionate about neuro-immunology, to work on an @FWOVlaanderen-funded project at @uhasselt, @BIOMED_UHasselt. Interested? Check the link: uhasselt.be/en/about-hasse… @BBBelgium_ @y_efis @yBIS_BE @EVB_Org

Doctoraatsonderzoek Melissa Schepers (#UHasselt/ @MaastrichtU) brengt medicijn om #MultipleSclerose te kunnen stoppen weer stapje dichterbij 👇 @BIOMED_UHasselt @GLW_UHasselt bit.ly/45t2OLZ

Starting off the week on a good note!! 🥳 Check out another one of our newly published papers about how PDE4D isoforms affect neurite elongation, specifically in the context of Alzheimer's disease. @VanmierloTim @MaastrichtU @BIOMED_UHasselt link.springer.com/article/10.100…

In our team, we have PhD defenses followed by paper publications!🥳 Check out our most recent paper in Acta Neuropathologica about the epigenomic and transcriptomic profile of MS lesions. Congrats to everyone involved! 👏🏼👏🏼 @TianeAssia @BIOMED_UHasselt @MaastrichtU

Hora est! 👩🏻‍🎓 Yesterday marked a milestone in my academic career. I successfully defended my thesis “Relieving the epigenetic blockade in progressive MS - making remyelination accessible again”, the result of my joint PhD between @uhasselt and @MaastrichtU.

A big congratulations to our Dr. Tiane for defending her thesis titled: "Relieving the epigenetic blockade in progressive MS - making remyelination accesible again" Proud of you for this major achievement! 👏🏼👏🏼👏🏼 @BIOMED_UHasselt @MaastrichtU

Congratulations to Dr. Melissa Schepers for defending her PhD thesis on PDE4 inhibition: a novel approach to treat demyelinating disorders. 🥂 Proud of you for this major achievement👏🏼 Congratulations 🥳 @MaastrichtU @BIOMED_UHasselt @uhasselt

Our team is having a great start to 2023! Check out a preprint of our latest paper on the epigenomic and transcriptomic profile of chronically demyelinated MS lesions 🧠. Well done @TianeAssia!🥳 @biorxivpreprint @BIOMED_UHasselt

Excited to share our latest data on the epigenomic and transcriptomic profile of chronically demyelinated MS lesions, recently published as a preprint on bioRxiv. 🧬 @rice_science @VanmierloTim @BIOMED_UHasselt biorxiv.org/content/10.110…

Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis @VanmierloTim @rice_science @PNIRS @ELSneuroscience #OpenAccess #neuroinflammation #ms #MultipleSclerosis doi.org/10.1016/j.bbi.…

Check out our most recent paper about PDE4 subtype inhibition and its implications for multiple sclerosis. Congratulations to our Melissa Schepers, well done!!

At the very end of this year, I am excited to share our latest paper @rice_science in Brain, Behavior, and Immunity by Melissa Schepers. AddThis | Home doi.org/10.1016/j.bbi.…

Read about why PDE4 subtype inhibition is a promising strategy for therapy in demyelinating disease. Congrats, @rice_science team!

Do not forget to sign up for out #symposium (30.11.2022) and being part of setting up a new #network in #Belgium to bring researchers interested in blood brain barriers together. #BBBelgium uhasselt.be/en/aparte-site…

Catherine Lubetzki at #ECTRIMS2022 : Remyelination is currently THE major challenge in multiple sclerosis. Luckily we have quite some expertise about this at @BIOMED_UHasselt 😉